Oncology Times publishes news feature on HARMONY
HARMONY welcomes Pfizer as New Partner
A unified approach to leverage big data for blood cancer research ...
HARMONY Alliance newsletter: Latest updates in February 2020
Fact sheet: benefits of becoming an Associated Member
Mini-series on Big Data: three videos that explain it all
Highlights BioData World 2019: successful collaboration of the ...
Watch HARMONY’s journey toward enabling better
2019: Another triumphant year for the HARMONY Alliance!
Presenting the HARMONY Big Data Platform Infographic
Highlights HARMONY Alliance attendance at the 61st ASH Annual ...
Press Release: HARMONY Big Data Platform can improve prognostic ...
HARMONY wins ISPOR’s New Investigator Award 2019
Highlights from HARMONY's 4th General Assembly, hosted by HARMONY ...
Meet us at these upcoming international conferences in November ...
Progress Update: HARMONY gains momentum
4th General Assembly organized in Florence, Italy
Unique video: Aggregated data from 5 AML studies showing
Meet HARMONY at EHA24, 13-16 June, Amsterdam
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands